70 related articles for article (PubMed ID: 23856487)
21. CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.
Yoon Y; Liang Z; Zhang X; Choe M; Zhu A; Cho HT; Shin DM; Goodman MM; Chen ZG; Shim H
Cancer Res; 2007 Aug; 67(15):7518-24. PubMed ID: 17671223
[TBL] [Abstract][Full Text] [Related]
22. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
23. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
[TBL] [Abstract][Full Text] [Related]
24. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin.
Cardones AR; Murakami T; Hwang ST
Cancer Res; 2003 Oct; 63(20):6751-7. PubMed ID: 14583470
[TBL] [Abstract][Full Text] [Related]
25. Plerixafor Improves Primary Tumor Response and Reduces Metastases in Cervical Cancer Treated with Radio-Chemotherapy.
Chaudary N; Pintilie M; Jelveh S; Lindsay P; Hill RP; Milosevic M
Clin Cancer Res; 2017 Mar; 23(5):1242-1249. PubMed ID: 27697997
[No Abstract] [Full Text] [Related]
26. A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer.
Huang EH; Singh B; Cristofanilli M; Gelovani J; Wei C; Vincent L; Cook KR; Lucci A
J Surg Res; 2009 Aug; 155(2):231-6. PubMed ID: 19482312
[TBL] [Abstract][Full Text] [Related]
27. The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis.
Arya M; Patel HR; McGurk C; Tatoud R; Klocker H; Masters J; Williamson M
J Exp Ther Oncol; 2004 Dec; 4(4):291-303. PubMed ID: 15844659
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
[TBL] [Abstract][Full Text] [Related]
29. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
Zhang MX; Han N; Yu SY; Leng Y
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
[TBL] [Abstract][Full Text] [Related]
30. Role of the CXCR4/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma.
Clements D; Markwick LJ; Puri N; Johnson SR
J Immunol; 2010 Aug; 185(3):1812-21. PubMed ID: 20585037
[TBL] [Abstract][Full Text] [Related]
31. Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation.
Chaudary N; Pintilie M; Hedley D; Fyles AW; Milosevic M; Clarke B; Hill RP; Mackay H
Cancer; 2012 Jun; 118(12):3105-15. PubMed ID: 22028038
[TBL] [Abstract][Full Text] [Related]
32. Stromal cell-derived factor-1α and macrophage migration-inhibitory factor induce metastatic behavior in CXCR4-expressing colon cancer cells.
Shin HN; Moon HH; Ku JL
Int J Mol Med; 2012 Dec; 30(6):1537-43. PubMed ID: 23023114
[TBL] [Abstract][Full Text] [Related]
33. Systemic hypoxia differentially affects neurogenesis during early mouse brain maturation.
Schneider C; Krischke G; Rascher W; Gassmann M; Trollmann R
Brain Dev; 2012 Apr; 34(4):261-73. PubMed ID: 21824737
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
[TBL] [Abstract][Full Text] [Related]
35. Hedgehog inhibition enhances efficacy of radiation and cisplatin in orthotopic cervical cancer xenografts.
Chaudary N; Pintilie M; Hedley D; Hill RP; Milosevic M; Mackay H
Br J Cancer; 2017 Jan; 116(1):50-57. PubMed ID: 27875522
[TBL] [Abstract][Full Text] [Related]
36. The Oral CXCR4 Inhibitor X4-136 Improves Tumor Control and Reduces Toxicity in Cervical Cancer Treated With Radiation Therapy and Concurrent Chemotherapy.
Chaudary N; Hill RP; Stulik L; Milosevic M
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1317-1324. PubMed ID: 33771702
[TBL] [Abstract][Full Text] [Related]
37. Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy.
Lecavalier-Barsoum M; Chaudary N; Han K; Pintilie M; Hill RP; Milosevic M
Br J Cancer; 2019 Jul; 121(3):249-256. PubMed ID: 31239542
[TBL] [Abstract][Full Text] [Related]
38. Quantitative Longitudinal Imaging Reveals that Inhibiting Hedgehog Activity Alleviates the Hypoxic Tumor Landscape.
Lama-Sherpa TD; Das S; Hinshaw DC; Kammerud SC; Song PN; Alsheikh HA; Sorace AG; Samant RS; Shevde LA
Mol Cancer Res; 2022 Jan; 20(1):150-160. PubMed ID: 34593607
[TBL] [Abstract][Full Text] [Related]
39. Anemia, hypoxia and transfusion in patients with cervix cancer: a review.
Fyles AW; Milosevic M; Pintilie M; Syed A; Hill RP
Radiother Oncol; 2000 Oct; 57(1):13-9. PubMed ID: 11033184
[TBL] [Abstract][Full Text] [Related]
40. The chemokine receptor CXCR4: a homing device for hypoxic cancer cells?
Pore N; Maity A
Cancer Biol Ther; 2006 Nov; 5(11):1563-5. PubMed ID: 17172811
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]